Literature DB >> 23649705

Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.

Tamás Gáll1, Andrea Kis, Tímea Zsófia Tatár, Gábor Kardos, Lajos Gergely, Krisztina Szarka.   

Abstract

This study aimed to compare complete genome sequences of human papillomavirus (HPV) type 11 from two solitary papillomas (considered minimally aggressive), two moderately (six and nine episodes) and two highly aggressive (30 and 33 episodes) juvenile-onset respiratory papillomatoses. Genomic regions were sequenced using the Sanger method; sequences were compared to available GenBank genomes. Activity of the long control region (LCR) was assessed in HEp-2 cell line using luciferase assays and compared to that of the reference (GenBank Accession Number M14119). Site-directed mutagenesis was performed to confirm the association of polymorphisms with differences in LCR activity. Eleven alterations resulted in amino acid changes in different open reading frames. A72E in E1 and Q86K in E2 proteins were exclusively present in a moderately aggressive disease, L1 alterations A476V and S486F were unique to a severe papillomatosis. HPV11s in both solitary papillomas had identical LCRs containing a T7546C polymorphism, which strongly attenuated LCR activity, as confirmed by site-directed mutagenesis. This strong attenuator polymorphism was also present in the other four genomes showing significantly higher activities, but in these other alterations with demonstrable but statistically not significant attenuating (A7413C, 7509 T deletion) or enhancing (C7479T, T7904A) effect on transactivating potential (as demonstrated by site-directed mutagenesis) were also detected. LCR activities corresponded well to severity, excepting the highly aggressive papillomatosis with the L1 alterations. Presence of intratypic variants cannot explain differences in severity of respiratory papillomatoses associated with HPV11; virulence seems to be determined by the interaction of multiple genetic differences.

Entities:  

Mesh:

Year:  2013        PMID: 23649705     DOI: 10.1007/s00430-013-0297-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  48 in total

Review 1.  Mechanisms of cell transformation by papillomavirus E5 proteins.

Authors:  D DiMaio; D Mattoon
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

2.  Detection of HPV types and neutralizing antibodies in Gansu province, China.

Authors:  Xueling Wu; Chuntao Zhang; Shuxian Feng; Chunyu Liu; Yanqin Li; Yongxiu Yang; Jun Gao; Hongfang Li; Shufang Meng; Liping Li; Yunzhong Zhang; Xuemei Hu; Xiaolu Wu; Lin Lin; Xun Li; Youchun Wang
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

3.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Prevaccination genomic diversity of human papillomavirus genotype 11: a study on 63 clinical isolates and 10 full-length genome sequences.

Authors:  Polona J Maver; Boštjan J Kocjan; Katja Seme; Marko Potočnik; Nina Gale; Mario Poljak
Journal:  J Med Virol       Date:  2011-03       Impact factor: 2.327

5.  Human papillomavirus 6, 11, and 16 in laryngeal papillomas.

Authors:  P Dickens; G Srivastava; S L Loke; S Larkin
Journal:  J Pathol       Date:  1991-11       Impact factor: 7.996

6.  Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity.

Authors:  Christina Kämmer; Ursula Warthorst; Norah Torrez-Martinez; Cosette M Wheeler; Herbert Pfister
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

7.  Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region.

Authors:  G Veress; M Murvai; K Szarka; A Juhász; J Kónya; L Gergely
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

8.  Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.

Authors:  Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro; Immacolata Salatiello; Elke Beth-Giraldo; Gaetano Giraldo
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

9.  Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.

Authors:  C M Chiang; M Ustav; A Stenlund; T F Ho; T R Broker; L T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

10.  Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly.

Authors:  Brooke Bishop; Jhimli Dasgupta; Xiaojiang S Chen
Journal:  Virol J       Date:  2007-01-08       Impact factor: 4.099

View more
  4 in total

1.  The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.

Authors:  Anita Szalmás; Vjekoslav Tomaić; Om Basukala; Paola Massimi; Suruchi Mittal; József Kónya; Lawrence Banks
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

2.  Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences.

Authors:  Mateja M Jelen; Zigui Chen; Boštjan J Kocjan; Lea Hošnjak; Felicity J Burt; Paul K S Chan; Diego Chouhy; Catharina E Combrinck; Christine Estrade; Alison Fiander; Suzanne M Garland; Adriana A Giri; Joaquín Víctor González; Arndt Gröning; Sam Hibbitts; Tommy N M Luk; Karina Marinic; Toshihiko Matsukura; Anna Neumann; Anja Oštrbenk; Maria Alejandra Picconi; Martin Sagadin; Roland Sahli; Riaz Y Seedat; Katja Seme; Alberto Severini; Jessica L Sinchi; Jana Smahelova; Sepehr N Tabrizi; Ruth Tachezy; Sarah Tohme Faybush; Virgilijus Uloza; Ingrida Uloziene; Yong Wee Wong; Snježana Židovec Lepej; Robert D Burk; Mario Poljak
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 3.  Regulation of HPV transcription.

Authors:  Aline Lopes Ribeiro; Amanda Schiersner Caodaglio; Laura Sichero
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

Review 4.  Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.

Authors:  R Y Seedat
Journal:  Pediatric Health Med Ther       Date:  2020-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.